Market Movers

Novartis to Sell US Derma Business, Oral Solids Portfolio to Aurobindo for Up to $1 Billion

September 6, 2018 at 8:54 am

Swiss drugmaker Novartis (NOVN.SW, NVS) has agreed to sell portions of its Sandoz US portfolio to Aurobindo Pharma USA for up to $1 billion as it seeks to focus the Sandoz division on higher growth areas. The company said on Thursday that it will divest the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo Pharma USARead More

Verint Systems Shares Jump as Second Quarter Results Beat Expectations

September 6, 2018 at 8:52 am

Shares in Verint Systems (VRNT), a supplier of security intelligence solutions, surged in post-market trading after the firm said late on Wednesday that its focus on “actionable intelligence innovation” had underpinned revenues and adjusted earnings in its fiscal second quarter which beat analysts’ expectations. Group sales rose to $306.3 million in the three months to July 31, from $274.8 millionRead More

Lilly Spinoff Elanco Animal Health Seeks to Raise $1.45 Billion in Initial Public Offering

September 6, 2018 at 8:51 am

Eli Lilly and Company (LLY) spinoff Elanco Animal Health Inc. said in a regulatory filing on Thursday that it will raise up to $1.45 billion in its initial public offering. The company said in a filing with the Securities and Exchange Commission that it will offer 62.9 million shares of common stock for $20 to $23 per unit under theRead More

BeyondSpring Says Data Demonstrate Potential of Plinabulin as Cancer Care Drug

September 6, 2018 at 8:49 am

BeyondSpring (BYSI) said pre-market Thursday that its lead asset, Plinabulin, a novel, non-G-CSF small molecule in development for the prevention of chemotherapy-induced neutropenia (CIN) and for the treatment of non-small cell lung cancer (NSCLC), mitigated both docetaxel CIN and thrombocytopenia in patients with advanced NSCLC in its phase 2 trial. The biopharmaceutical company said that the data demonstrate Plinabulins’ potentialRead More

US Equity Futures Trade Sideways; Asia Sloppy Overnight, Jones Trading Says

September 6, 2018 at 7:49 am

US equity futures were drifting sideways early Thursday, as traders awaited headers on the next round of tariffs on $200 billion of Chinese imports, said Dave Lutz, head of ETFs at Jones Trading. The Nasdaq led to the downside for the second-straight day as a regulatory storm brewed. Over in Europe, the DAX attempted to shrug off a five-day slideRead More